Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences? Editorial Article uri icon

Overview

abstract

  • Few clinical issues have polarized the oncology community as much as screening for prostate cancer, with advocates of prostate-specific antigen (PSA) testing vocal on one side and skeptics just as vocal on the other. At the NCCN 19th Annual Conference, Dr. Peter R. Carroll and Dr. Andrew J. Vickers tackled the controversy surrounding early detection of prostate cancer, focusing attention on the randomized trial results at the heart of the matter; over-detection (the Achilles' heel of screening); and the rationale behind the new, streamlined 2014 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection, which emphasize selective early detection and treatment and are tightly aligned with the NCCN Guidelines for Prostate Cancer.

publication date

  • May 1, 2014

Research

keywords

  • Early Detection of Cancer
  • Prostatic Neoplasms

Identity

Scopus Document Identifier

  • 84902477822

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2014.0186

PubMed ID

  • 24853213

Additional Document Info

volume

  • 12

issue

  • 5 Suppl